ATE350031T1 - Synergistische leberschützende zusammensetzung und verfahren dazu - Google Patents

Synergistische leberschützende zusammensetzung und verfahren dazu

Info

Publication number: ATE350031T1
Authority: AT; Austria
Prior art keywords: tca; formulation; synergistic; tetracos; hepatoprotection
Prior art date: 2003-03-31

Application number

AT03717533T

Other languages

English (en)

Inventor

Vishwa Nath Gupta

Krishan Avtar Suri

Bishan Datt Gupta

Bupinder Singh Jaggi

Naresh Kumar Satti

Bal Krishan Chandan

Neelam Sharma

Vikram Bhardwaj

Om Parkash Suri

Ghulam Nabi Qazi

Jyotsna Suri

Madalsa Bargotra

Original Assignee

Council Scient Ind Res

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-03-31

Filing date

2003-03-31

Publication date

2007-01-15

2003-03-31 Application filed by Council Scient Ind Res filed Critical Council Scient Ind Res

2007-01-15 Application granted granted Critical

2007-01-15 Publication of ATE350031T1 publication Critical patent/ATE350031T1/de

Links

239000000203 mixture Substances 0.000 title abstract 7
238000000034 method Methods 0.000 title abstract 5
230000002195 synergetic effect Effects 0.000 title abstract 4
BOJKULTULYSRAS-OTESTREVSA-N Andrographolide Chemical compound C([C@H]1[C@]2(C)CC[C@@H](O)[C@]([C@H]2CCC1=C)(CO)C)\C=C1/[C@H](O)COC1=O BOJKULTULYSRAS-OTESTREVSA-N 0.000 abstract 7
ASLUCFFROXVMFL-UHFFFAOYSA-N andrographolide Natural products CC1(CO)C(O)CCC2(C)C(CC=C3/C(O)OCC3=O)C(=C)CCC12 ASLUCFFROXVMFL-UHFFFAOYSA-N 0.000 abstract 7
238000009472 formulation Methods 0.000 abstract 5
GWHCXVQVJPWHRF-UHFFFAOYSA-N cis-tetracosenoic acid Natural products CCCCCCCCC=CCCCCCCCCCCCCCC(O)=O GWHCXVQVJPWHRF-UHFFFAOYSA-N 0.000 abstract 3
GWHCXVQVJPWHRF-MDZDMXLPSA-N trans-selacholeic acid Chemical compound CCCCCCCC\C=C\CCCCCCCCCCCCCC(O)=O GWHCXVQVJPWHRF-MDZDMXLPSA-N 0.000 abstract 3
239000010419 fine particle Substances 0.000 abstract 2
239000002245 particle Substances 0.000 abstract 1
238000002360 preparation method Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Diabetes (AREA)
Epidemiology (AREA)
Hematology (AREA)
Gastroenterology & Hepatology (AREA)
Obesity (AREA)
Endocrinology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Plant Substances (AREA)
Medicinal Preparation (AREA)
Seasonings (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Steroid Compounds (AREA)

AT03717533T 2003-03-31 2003-03-31 Synergistische leberschützende zusammensetzung und verfahren dazu ATE350031T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PCT/IN2003/000129 WO2004087127A1 (en)	2003-03-31	2003-03-31	Synergistic hepatoprotective composition and a method thereof

Publications (1)

Publication Number	Publication Date
ATE350031T1 true ATE350031T1 (de)	2007-01-15

Family

ID=33104978

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT03717533T ATE350031T1 (de)	2003-03-31	2003-03-31	Synergistische leberschützende zusammensetzung und verfahren dazu

Country Status (6)

Country	Link
EP (1)	EP1608360B1 (de)
JP (1)	JP2006514975A (de)
AT (1)	ATE350031T1 (de)
AU (1)	AU2003222445A1 (de)
DE (1)	DE60311013T2 (de)
WO (1)	WO2004087127A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN104096045A (zh) *	2014-07-01	2014-10-15	胥玲	治疗痛风性关节炎的中药组合物
CN116003239B (zh) *	2022-11-27	2024-05-17	上海中医药大学	双环二萜类衍生物、其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2001256570A1 (en) *	2000-05-05	2001-11-20	Dr. Reddy's Research Foundation	Novel anticancer compounds: process for their preparation and pharmaceutical compositions containing them
US6629835B2 (en) *	2000-08-01	2003-10-07	Metaproteomics, Llc	Combinations of diterpene triepoxide lactones and ditepene lactones or triterpenes for synergistic inhibition of cyclooxygenase-2

2003
- 2003-03-31 WO PCT/IN2003/000129 patent/WO2004087127A1/en not_active Ceased
- 2003-03-31 EP EP03717533A patent/EP1608360B1/de not_active Expired - Lifetime
- 2003-03-31 JP JP2004570098A patent/JP2006514975A/ja active Pending
- 2003-03-31 AU AU2003222445A patent/AU2003222445A1/en not_active Abandoned
- 2003-03-31 AT AT03717533T patent/ATE350031T1/de not_active IP Right Cessation
- 2003-03-31 DE DE60311013T patent/DE60311013T2/de not_active Expired - Lifetime

Also Published As

Publication number	Publication date
WO2004087127A1 (en)	2004-10-14
EP1608360A1 (de)	2005-12-28
JP2006514975A (ja)	2006-05-18
DE60311013T2 (de)	2007-10-11
EP1608360B1 (de)	2007-01-03
DE60311013D1 (de)	2007-02-15
AU2003222445A1 (en)	2004-10-25

Similar Documents

Publication	Publication Date	Title
DE69811233D1 (de)	2003-03-13	Feste lösungen und dispersionen von eines schlecht wasserlöslichen wirkstoffes
BRPI0413394A8 (pt)	2016-03-08	Formulação de lantânio mastigável em tablete, formulação farmacêutica em tablete ou em pó, método para tratar hiperfosfatemia, uso de uma quantidade terapeuticamente efetiva de uma formulação de um composto de lantânio, processo para preparar uma formulação em tablete de um composto de lantânio
ATE249422T1 (de)	2003-09-15	Verbindungen und zusammensetzungen zur verabreichung aktiver stoffe
SG146648A1 (en)	2008-10-30	Pharmaceutical compositions for treating premature ejaculation by pulmonary inhalation
DE60134535D1 (de)	2008-08-07	Micelläre arzneimittel zur bukkalen und pulmonaren anwendung
WO2003072713A3 (en)	2004-12-23	Use of bcma as an immunoregulatory agent
WO2004091521A3 (en)	2005-03-03	Methods and compositions for administration of trpv1 agonists
ATE408401T1 (de)	2008-10-15	Granulat oder pulver zur herstellung von überzugs-und bindemitteln für arzneiformen
ATE434439T1 (de)	2009-07-15	Verfahren zu herstellung von zubereitungen enthaltend einen steroidhormon und ein stabilisierungsmittel in nicht-kristallinen form
IL164217A0 (en)	2005-12-18	Pharmaceutical compositions containing water-soluble propofol and methods of administering same
IL160171A0 (en)	2004-07-25	Depsipeptide derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
IL172602A0 (en)	2006-04-10	Stable pharmaceutical compositions of 2-aza-bicyclo[3.3.0]- octane-3-carboxylic acid deriv atives
WO2004016243A3 (en)	2004-05-21	Methods of administering and enhancing absorption of pharmaceutical agents
MY137846A (en)	2009-03-31	Processes for the preparation of oral dosage formulations of modafinil
ATE350031T1 (de)	2007-01-15	Synergistische leberschützende zusammensetzung und verfahren dazu
ATE298567T1 (de)	2005-07-15	Pharmazeutische zusammensetzung enthaltend ibuprofen und ein verfahren zur deren herstellung
CY1113221T1 (el)	2016-04-13	Διεργασια για την παρασκευη ενος φαρμακου
AU2003267551A1 (en)	2004-03-11	Thieno-pyrrole compounds as antagonists of gonadotropin releasing hormone
KR102164102B1 (ko)	2020-10-12	화산석 송이를 포함하는 무스제형 화장료 조성물
WO2006030301A8 (en)	2008-10-09	Cilostazol- containing pharmaceutical composition based on particles of less than 50 micrometers
CO4940482A1 (es)	2000-07-24	Composiciones farmaceuticas conteniendo 3-de-o-acylo lipido monofosforilo a y procedimiento de preparacion
DE60102084D1 (de)	2004-03-25	Propanolaminotetraline, verfahren zu ihrer herstellung sowie diese verbindungen enthaltende pharmazeutische zusammensetzungen
KR20180055670A (ko)	2018-05-25	미세먼지 흡착 방지용 화장료 조성물
WO2004103408A3 (fr)	2005-03-17	Composition vaccinale comprenant du phosphate de fer a titre d’adjuvant vaccinal
IL160160A0 (en)	2004-07-25	SUBSTITUTED 5,6,6a, 11b-TETRAHYDRO-7-OXA-5-AZA-BENZO[c]FLUORENE-6-CARBOXYLIC ACID DERIVATIVES SERVING AS NMDA ANTAGONISTS

Legal Events

Date	Code	Title	Description
2007-07-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties